JA SH Influenza Vaccine 2019 Edited JW 12-5-19 pdf_Redacted.pdf
PDF 169 KB Posted
- Attached to
- Southern Hemisphere Influenza Vaccine
- Solicitation number
- SPE2DP20R0116
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Justification for Other than Full and Open Competition In accordance with 10 USC 2304 (c)(1)
Southern Hemisphere Influenza Vaccine
“Source Selection Information – See FAR 2.101 and 3.104”
1. Defense Logistics Agency (DLA) Troop Support, Medical Supply Chain, is the contracting activity.
2. The action being approved is the ability to solicit for DLA requirements on an other than full and open competition basis.
3. The proposed acquisition will result in a one (1) year firm fixed price definite quantity contract for the Southern Hemisphere Influenza Vaccine. The sole source for this vaccine is Sanofi Pasteur Inc.
National Stock Number (NSN): 6505-01-685-1655 Annual Quantity: 2,900 Packages (PG), 29,000 doses Maximum Quantity: 2,900 PG, 29,000 doses Estimated Unit Price:
Federal Excise Tax (FET):
Estimated Dollar Value: ) Maximum Dollar Value: )
The annual quantity is based on the requirements received from the Services.
4. The applicable statutory authority permitting other than full and open competition is 10 U.S.C. 2304(c)(1), implemented by FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements.
5. Fluzone® Quadrivalent Southern Hemisphere is a vaccine indicated for active immunization for the prevention of the influenza virus. Fluzone Quadrivalent Southern Hemisphere is approved for use in persons 6 months of age and older. A quadrivalent vaccine includes four (4) different strains of the flu virus. Multiple strains of influenza virus circulate in the population every year and the immune response is different to each of these strains, so an effective vaccine gives protection against each. The Southern Hemisphere Influenza Vaccine is considered necessary for that sector of the population that is located in the Southern Hemisphere, where the Influenza season runs from April through September.
6. In accordance with FAR 5.2, this requirement will be synopsized on beta.SAM.gov In addition, this justification will be made available for public inspection, after award, in accordance with FAR.6.305(a). This procurement is being solicited under a specification with essential characteristics.
Justification for Other than Full and Open Competition In accordance with 10 USC 2304 (c)(1)
Southern Hemisphere Influenza Vaccine
“Source Selection Information – See FAR 2.101 and 3.104”
7. As the Contracting Officer, I hereby determine that the anticipated cost to the Government will be fair and reasonable based on an analysis of other than certified cost and pricing data.
8. Market research indicates that Sanofi Pasteur has been the sole manufacturer of the Southern Hemisphere Flu vaccine
As part of market research, a Sources Sought notice was posted on FedBizOpps on October 21, 2019 for 30 days, in an attempt to find alternate sources for the vaccine, and also to investigate if alternate sources are currently being developed. It closed on November 21, 2019 with only one response received from Sanofi Pasteur.
DLA Troop Support, in conjunction with The Defense Health Agency Immunization Healthcare Division (DHA-IHD) at Falls Church, Virginia will continue to perform market research prior to any future acquisitions for the requirement.
9. There are no other facts supporting the use of Other Than Full and Open Competition.
10. The only known source for the supply of Southern Hemisphere Influenza Virus Vaccine is Sanofi Pasteur, Swiftwater, Pennsylvania, which has expressed interest in writing to fulfill the Government’s requirements for this type of vaccine.
11.
In an effort to foster competition, however, the Government has produced a specification with essential characteristics and will advertise the requirements as stated in paragraph six (6) above. In accordance with FAR 6.302- 1(d)(2), any proposal in response to this notice will be considered.
12. The undersigned Contracting Officer hereby certifies that the information contained in this justification is accurate and complete to the best of her knowledge and belief.
Date JENNA WESOLOWSKI
Contracting Officer
12-5-2019
File details come from the government source that posted it. Updated .